Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Baricitinib plus Remdesivir for Hospitalized Adults with COVID-19

Efficacy of Tocilizumab in Patients Hospitalized with COVID-19

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with COVID-19

A Neutralizing Monoclonal Antibody for Hospitalized Patients with COVID-19

Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine

Happy New Year 2021 from the EAN, the Home of Neurology

For January 2021, we have selected: Matschke et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol 2020; 19:919-929. doi: 10.1016/S1474-4422(20)30308-2.

EMA and the Heads of Medicines Agencies (HMA) have published their joint strategy for the next five years, following its recent adoption by the HMA and EMA Management Board.

2020 - BioMed Alliance celebrates 10 years of existence

9 December 2020, during an online European Parliament workshop hosted by Sirpa Pietikäinen MEP (Finland), Alzheimer Europe will launch its new report “Dementia as a European Priority – A Policy Overview” which takes stock of dementia policy at an EU… Continue Reading

Alzheimer Europe has launched two new publications: “Intercultural dementia care for health and social care providers: a guide” and “Policy briefing on intercultural care and support for people with dementia and their informal carers/supporters”.

The Education Committee is happy to announce the selection of candidates for the Clinical Fellowship Programme 2021.

As a Christmas Special to EAN’s RRFS members, we hosted a series of three Master Classes in the course of December 2020 for free.

Executive Page: Welcome to new year by Editor-in-Chief